Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Hamid Najminejad, Seyed Mehdi Kalantar, Ali Rezaei Mokarram, Mehran Dabaghian, Meghdad Abdollahpour-Alitappeh, Seyyed Mahmoud Ebrahimi, Majid Tebianian, Mahdi Fasihi Ramandi & Mohammad Hasan Sheikhha. (2019) Bordetella pertussis antigens encapsulated into N-trimethyl chitosan nanoparticulate systems as a novel intranasal pertussis vaccine. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 2605-2611.
Read now
Read now
Andrew R Gorringe & Thomas E Vaughan. (2014) Bordetella pertussis fimbriae (Fim): relevance for vaccines. Expert Review of Vaccines 13:10, pages 1205-1214.
Read now
Read now
Nicolas Hegerle & Nicole Guiso. (2014)
Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines. Expert Review of Vaccines 13:9, pages 1135-1146.
Read now
Read now
Vincenzo Baldo, Paolo Bonanni, Marcela Castro, Giovanni Gabutti, Elisabetta Franco, Federico Marchetti, Rosa Prato & Francesco Vitale. (2014) Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b vaccine; Infanrix™ hexa. Human Vaccines & Immunotherapeutics 10:1, pages 129-137.
Read now
Read now
Daniel Cozens & Robert C Read. (2012) Anti-adhesion methods as novel therapeutics for bacterial infections. Expert Review of Anti-infective Therapy 10:12, pages 1457-1468.
Read now
Read now
Jan T Poolman, Hans Hallander & Scott A Halperin. (2011) Pertussis vaccines: where to now?. Expert Review of Vaccines 10:11, pages 1497-1500.
Read now
Read now
Teemu Kallonen & Qiushui He. (2009) Bordetella pertussis strain variation and evolution postvaccination. Expert Review of Vaccines 8:7, pages 863-875.
Read now
Read now
Articles from other publishers (42)
Danyal Imani, Tannaz Bahadori, Sedighe Ghourchian, Forough Golsaz-Shirazi, Masoumeh Douraghi, Mahmood Jeddi-Tehrani, Mohammad Mehdi Amiri & Fazel Shokri. (2023) Novel mouse monoclonal antibodies against Bordetella pertussis pertactin antigen with versatile applications. Journal of Microbiological Methods 211, pages 106786.
Crossref
Crossref
Beatriz Miguelena Chamorro, Karelle De Luca, Gokul Swaminathan, Stéphanie Longet, Egbert Mundt & Stéphane Paul. (2023) Bordetella bronchiseptica and Bordetella pertussis: Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations. Clinical Microbiology Reviews.
Crossref
Crossref
Nao Otsuka, Kentaro Koide, Masataka Goto, Kazunari Kamachi & Tsuyoshi Kenri. (2023) Fim3-dependent autoagglutination of Bordetella pertussis. Scientific Reports 13:1.
Crossref
Crossref
Hanqing He, Yao Zhu, Mingjuan Jin, Yang Zhou, Xuewen Tang, Rui Yan, Xuan Deng & Kun Chen. (2022) The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study. Vaccine 40:48, pages 6956-6962.
Crossref
Crossref
Md. Obayed Raihan, Brenna M. Espelien, Brett A. McGregor, Courtney Hanson, Afrina Brishti, Nathan A. Velaris, Travis D. Alvine, David S. Bradley, Matthew Nilles, Mikhail Y. Golovko, Junguk Hur & James E. Porter. (2022) Modulation of Inflammatory Signaling Molecules in Bordetella pertussis Antigen-Challenged Human Monocytes in Presence of Adrenergic Agonists. Vaccines 10:2, pages 321.
Crossref
Crossref
Markus Knuf, Hervé Haas, Pilar Garcia-Corbeira, Elisa Turriani, Piyali Mukherjee, Winnie Janssens & Valérie Berlaimont. (2021) Hexavalent vaccines: What can we learn from head-to-head studies?. Vaccine 39:41, pages 6025-6036.
Crossref
Crossref
Diana Keizner, Shakiba Ghaffari, Samaneh Beheshti, Elena Newman, David Tulumello, Marina Kirkitadze & Michael Leach. (2021) Quantitative microcapillary electrophoresis immunoassay (mCE IA) for end-to-end analysis of pertactin within in-process samples and Quadracel® vaccine. Journal of Pharmaceutical and Biomedical Analysis 204, pages 114284.
Crossref
Crossref
Ting Y. Wong, Jesse M. Hall, Evan S. Nowak, Dylan T. Boehm, Laura A. Gonyar, Erik L. Hewlett, Joshua C. Eby, Mariette Barbier & F. Heath Damron. (2019)
Analysis of the
In Vivo
Transcriptome of Bordetella pertussis during Infection of Mice
. mSphere 4:2.
Crossref
Crossref
Arezoo Asadi, Shabnam Razavi, Malihe Talebi & Mehrdad Gholami. (2018) A review on anti-adhesion therapies of bacterial diseases. Infection 47:1, pages 13-23.
Crossref
Crossref
Anne Marie Queenan, David J. Dowling, Wing Ki Cheng, Kellen Faé, Jeffrey Fernandez, Peter J. Flynn, Sweta Joshi, Spencer E. Brightman, Juan Ramirez, Jan Serroyen, Selma Wiertsema, Alexandre Fortanier, Germie van den Dobbelsteen, Ofer Levy & Jan Poolman. (2019) Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro. Vaccine 37:1, pages 80-89.
Crossref
Crossref
Anthony William MaressoAnthony William Maresso. 2019. Bacterial Virulence. Bacterial Virulence
177
194
.
Qing Chen, Gloria Lee, Candice Craig, Victoria Ng, Paul E. CarlsonJr.Jr., Deborah M. Hinton & Scott Stibitz. (2018)
A Novel Bvg-Repressed Promoter Causes
vrg
-Like Transcription of
fim3
but Does Not Result in the Production of Serotype 3 Fimbriae in Bvg
−
Mode Bordetella pertussis
. Journal of Bacteriology 200:20.
Crossref
Crossref
Christiane S. Eberhardt & Claire-Anne Siegrist. (2017) What Is Wrong with Pertussis Vaccine Immunity?. Cold Spring Harbor Perspectives in Biology 9:12, pages a029629.
Crossref
Crossref
Julieanne L. Vo, Gabriela Constanza Martínez Ortiz, Pramod Subedi, Shivakumar Keerthikumar, Suresh Mathivanan, Jason J. Paxman & Begoña Heras. (2017)
Autotransporter Adhesins in
Escherichia coli
Pathogenesis
. PROTEOMICS 17:23-24, pages 1600431.
Crossref
Crossref
Zenglan Li, Yan Zhang, Qi Wang, Zhengjun Li, Yongdong Liu, Songping Zhang, Guifeng Zhang, Guanghui Ma, Jian Luo & Zhiguo Su. (2016) Purification design and practice for pertactin, the third component of acellular pertussis vaccine, from Bordetella pertussis. Vaccine 34:34, pages 4032-4039.
Crossref
Crossref
Azadeh Safarchi, Sophie Octavia, Laurence Don Wai Luu, Chin Yen Tay, Vitali Sintchenko, Nicholas Wood, Helen Marshall, Peter McIntyre & Ruiting Lan. (2015) Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. Vaccine 33:46, pages 6277-6281.
Crossref
Crossref
Rita Austin & Tonya Shearin-Patterson. 2015. Practical Handbook of Microbiology, Third Edition. Practical Handbook of Microbiology, Third Edition
745
766
.
P Sumarno R, S Avanita A, Winarsih S, Hidayat S & Y Nurhidayati D. (2015) Haemaglutination of Shigella dysenteriae subunit pili protein with anti-haemaglutination of S. dysenteriae subunit pili protein as a molecule adhesion in mouse enterocytes. African Journal of Microbiology Research 9:11, pages 781-787.
Crossref
Crossref
Na-Young Ha, Prashant Sharma, Gwanghun Kim, Yuri Kim, Chan-Ki Min, Myung-Sik Choi, Ik-Sang Kim & Nam-Hyuk Cho. (2015) Immunization with an Autotransporter Protein of Orientia tsutsugamushi Provides Protective Immunity against Scrub Typhus. PLOS Neglected Tropical Diseases 9:3, pages e0003585.
Crossref
Crossref
S. W. Martin, L. Pawloski, M. Williams, K. Weening, C. DeBolt, X. Qin, L. Reynolds, C. Kenyon, G. Giambrone, K. Kudish, L. Miller, D. Selvage, A. Lee, T. H. Skoff, H. Kamiya, P. K. Cassiday, M. L. Tondella & T. A. Clark. (2014) Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage. Clinical Infectious Diseases 60:2, pages 223-227.
Crossref
Crossref
Shwu-Maan Lee, Vincent Turula, Bradford Powell, Mikkel Nissum, Mariagrazia Pizza, Claudia Magagnoli & Niranjan M. Kumar. 2015. Vaccine Analysis: Strategies, Principles, and Control. Vaccine Analysis: Strategies, Principles, and Control
187
270
.
Thomas E. Vaughan, Catherine B. Pratt, Katie Sealey, Andrew Preston, Norman K. Fry & Andrew R. Gorringe. (2014) Plasticity of fimbrial genotype and serotype within populations of Bordetella pertussis: analysis by paired flow cytometry and genome sequencing. Microbiology 160:9, pages 2030-2044.
Crossref
Crossref
Qing Chen, Alice Boulanger, Deborah M. Hinton & Scott Stibitz. (2014)
Strong inhibition of fimbrial 3 subunit gene transcription by a novel downstream repressive element in
B
ordetella pertussis
. Molecular Microbiology 93:4, pages 748-758.
Crossref
Crossref
Kerrie Vaughan, Emily Seymour, Bjoern Peters & Alessandro Sette. (2014) Substantial gaps in knowledge of Bordetella pertussis antibody and T cell epitopes relevant for natural immunity and vaccine efficacy. Human Immunology 75:5, pages 440-451.
Crossref
Crossref
Derek S. Sarovich, Erin P. Price, Jessica R. Webb, Linda M. Ward, Marcos Y. Voutsinos, Apichai Tuanyok, Mark Mayo, Mirjam Kaestli & Bart J. Currie. (2014) Variable Virulence Factors in Burkholderia pseudomallei (Melioidosis) Associated with Human Disease. PLoS ONE 9:3, pages e91682.
Crossref
Crossref
Hans Hallander, Abdolreza Advani, Frances Alexander, Lennart Gustafsson, Margaretha Ljungman, Catherine Pratt, Ian Hall & Andrew R. Gorringe. (2014) Antibody Responses to Bordetella pertussis Fim2 or Fim3 following Immunization with a Whole-Cell, Two-Component, or Five-Component Acellular Pertussis Vaccine and following Pertussis Disease in Children in Sweden in 1997 and 2007. Clinical and Vaccine Immunology 21:2, pages 165-173.
Crossref
Crossref
Begoña HerasMakrina TotsikaKate M. PetersJason J. Paxman, Christine L. Gee, Russell J. Jarrott, Matthew A. PeruginiAndrew E. Whitten & Mark A. Schembri. (2013) The antigen 43 structure reveals a molecular Velcro-like mechanism of autotransporter-mediated bacterial clumping. Proceedings of the National Academy of Sciences 111:1, pages 457-462.
Crossref
Crossref
Yusuke Miyaji, Nao Otsuka, Hiromi Toyoizumi-Ajisaka, Keigo Shibayama & Kazunari Kamachi. (2013) Genetic Analysis of Bordetella pertussis Isolates from the 2008–2010 Pertussis Epidemic in Japan. PLoS ONE 8:10, pages e77165.
Crossref
Crossref
Birgit Thierry-Carstensen, Tine Dalby, Michael A. Stevner, John B. Robbins, Rachel Schneerson & Birger Trollfors. (2013) Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults—A review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Vaccine 31:45, pages 5178-5191.
Crossref
Crossref
Françoise Vermeulen, Violette Dirix, Virginie Verscheure, Eliane Damis, Danièle Vermeylen, Camille Locht & Françoise Mascart. (2013) Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: Comparison of three different vaccines and effect of a booster dose. Vaccine 31:15, pages 1981-1986.
Crossref
Crossref
Frances Alexander, Mary Matheson, Norman K. Fry, Briony Labram & Andrew R. Gorringe. (2012) Antibody Responses to Individual Bordetella pertussis Fimbrial Antigen Fim2 or Fim3 following Immunization with the Five-Component Acellular Pertussis Vaccine or to Pertussis Disease. Clinical and Vaccine Immunology 19:11, pages 1776-1783.
Crossref
Crossref
Birgit Thierry-Carstensen, Karina Jordan, Hilde Hylland Uhlving, Tine Dalby, Charlotte Sørensen, Anders Mørup Jensen & Carsten Heilmann. (2012) A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults. Vaccine 30:37, pages 5464-5471.
Crossref
Crossref
Na-Young Ha, Nam-Hyuk Cho, Yeon-Sook Kim, Myung-Sik Choi & Ik-Sang Kim. (2011)
An Autotransporter Protein from
Orientia tsutsugamushi
Mediates Adherence to Nonphagocytic Host Cells
. Infection and Immunity 79:4, pages 1718-1727.
Crossref
Crossref
Sandra Morel, Philippe Denoël, Fabrice Godfroid, Caroline Cortvrindt, Nathalie Vanderheyde & Jan Poolman. (2011) Induction of Bordetella pertussis-specific immune memory by DTPa vaccines. Vaccine 29:18, pages 3449-3455.
Crossref
Crossref
Estela M. Galván, Manoj Kumar Mohan Nair, Huaiqing Chen, Fabio Del Piero & Dieter M. Schifferli. (2010) Biosafety Level 2 Model of Pneumonic Plague and Protection Studies with F1 and Psa. Infection and Immunity 78:8, pages 3443-3453.
Crossref
Crossref
D. Hozbor, F. Mooi, D. Flores, G. Weltman, D. Bottero, S. Fossati, C. Lara, M.E. Gaillard, L. Pianciola, E. Zurita, A. Fioriti, D. Archuby, M. Galas, N. Binsztein, M. Regueira, C. Castuma, M. Fingermann & A. Graieb. (2009) Pertussis epidemiology in Argentina: trends over 2004–2007. Journal of Infection 59:4, pages 225-231.
Crossref
Crossref
HANS O. HALLANDER, MARGARETHA LJUNGMAN, MAJA JAHNMATZ, JANN STORSAETER, LENNART NILSSON & LENNART GUSTAFSSON. (2009) Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection. APMIS 117:9, pages 660-671.
Crossref
Crossref
Elizabeth M. Goebel, Xuqing Zhang & Eric T. Harvill. (2009) Bordetella pertussis Infection or Vaccination Substantially Protects Mice against B. bronchiseptica Infection. PLoS ONE 4:8, pages e6778.
Crossref
Crossref
Claudia Gianfaldoni, Silvia Maccari, Laura Pancotto, Giacomo Rossi, Markus Hilleringmann, Werner Pansegrau, Antonia Sinisi, Monica Moschioni, Vega Masignani, Rino Rappuoli, Giuseppe Del Giudice & Paolo Ruggiero. (2009)
Sortase A Confers Protection against
Streptococcus pneumoniae
in Mice
. Infection and Immunity 77:7, pages 2957-2961.
Crossref
Crossref
M.L. Tondella, G.M. Carlone, N. Messonnier, C.P. Quinn, B.D. Meade, D.L. Burns, J.D. Cherry, N. Guiso, E.L. Hewlett, K.M. Edwards, D. Xing, A. Giammanco, C.H. Wirsing von König, L. Han, L. Hueston, J.B. Robbins, M. Powell, C.M. Mink, J.T. Poolman, S.W. Hildreth, F. Lynn & A. Morris. (2009) International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19–20 July 2007. Vaccine 27:6, pages 803-814.
Crossref
Crossref
Nico Marr, David C. Oliver, Vincianne Laurent, Jan Poolman, Philippe Denoël & Rachel C. Fernandez. (2008) Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model. Vaccine 26:34, pages 4306-4311.
Crossref
Crossref
Bob Medhekar & Jeff F Miller. (2007) Diversity-generating retroelements. Current Opinion in Microbiology 10:4, pages 388-395.
Crossref
Crossref